321 related articles for article (PubMed ID: 26714943)
1. Sentinel Lymph Node Mapping in Post-Mastectomy Chest Wall Recurrences: Influence on Radiation Treatment Fields and Outcome.
Johnson J; Esserman L; Ewing C; Alvarado M; Park C; Fowble B
Ann Surg Oncol; 2016 Mar; 23(3):715-21. PubMed ID: 26714943
[TBL] [Abstract][Full Text] [Related]
2. Reoperative Sentinel Lymph Node Biopsy is Feasible for Locally Recurrent Breast Cancer, But is it Worthwhile?
Ugras S; Matsen C; Eaton A; Stempel M; Morrow M; Cody HS
Ann Surg Oncol; 2016 Mar; 23(3):744-8. PubMed ID: 26644258
[TBL] [Abstract][Full Text] [Related]
3. Long-term prognoses and outcomes of axillary lymph node recurrence in 2,578 sentinel lymph node-negative patients for whom axillary lymph node dissection was omitted: results from one Japanese hospital.
Ogiya A; Kimura K; Nakashima E; Sakai T; Miyagi Y; Iijima K; Morizono H; Makita M; Horii R; Akiyama F; Iwase T
Breast Cancer; 2016 Mar; 23(2):318-22. PubMed ID: 25376341
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of clinically node-negative breast cancer without axillary dissection: can preserved axilla be safely treated with radiation after a positive sentinel node biopsy?
Sanuki N; Takeda A; Amemiya A; Ofuchi T; Ono M; Ogata H; Yamagami R; Hatayama J; Eriguchi T; Kunieda E
Clin Breast Cancer; 2013 Feb; 13(1):69-76. PubMed ID: 23062706
[TBL] [Abstract][Full Text] [Related]
5. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer.
Inoue T; Nishi T; Nakano Y; Nishimae A; Sawai Y; Yamasaki M; Inaji H
Breast Cancer; 2016 Mar; 23(2):295-300. PubMed ID: 25348937
[TBL] [Abstract][Full Text] [Related]
6. Staging and management of axillary lymph nodes in patients with local recurrence in the breast or chest wall after a previous negative sentinel node procedure.
Derkx F; Maaskant-Braat AJ; van der Sangen MJ; Nieuwenhuijzen GA; van de Poll-Franse LV; Roumen RM; Voogd AC
Eur J Surg Oncol; 2010 Jul; 36(7):646-51. PubMed ID: 20537838
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer patients with extra-axillary sentinel nodes only may be spared axillary lymph node dissection.
van der Ploeg IM; Tanis PJ; Valdés Olmos RA; Kroon BB; Rutgers EJ; Nieweg OE
Ann Surg Oncol; 2008 Nov; 15(11):3239-43. PubMed ID: 18773244
[TBL] [Abstract][Full Text] [Related]
8. Axillary Surgery for Early-Stage, Node-Positive Mastectomy Patients and the Use of Postmastectomy Chest Wall Radiation Therapy.
Gaines S; Suss N; Barrera E; Pesce C; Kuchta K; Winchester DJ; Yao K
Ann Surg Oncol; 2018 Aug; 25(8):2220-2228. PubMed ID: 29626303
[TBL] [Abstract][Full Text] [Related]
9. Improving the Success Rate of Repeat Sentinel Node Biopsy in Recurrent Breast Cancer.
Vugts G; Maaskant-Braat AJ; Voogd AC; van Riet YE; Roumen RM; Luiten EJ; Rutgers EJ; Wyndaele D; Rutten HJ; Nieuwenhuijzen GA
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S529-35. PubMed ID: 26259754
[TBL] [Abstract][Full Text] [Related]
10. Sentinel node biopsy versus low axillary sampling in women with clinically node negative operable breast cancer.
Parmar V; Hawaldar R; Nair NS; Shet T; Vanmali V; Desai S; Gupta S; Rangrajan V; Mittra I; Badwe RA
Breast; 2013 Dec; 22(6):1081-6. PubMed ID: 23948301
[TBL] [Abstract][Full Text] [Related]
11. Contrast-Enhanced Ultrasound Biopsy of Sentinel Lymph Nodes in Patients with Breast Cancer: Implications for Axillary Metastases and Conservation.
Cox K; Weeks J; Mills P; Chalmers R; Devalia H; Fish D; Sever A
Ann Surg Oncol; 2016 Jan; 23(1):58-64. PubMed ID: 25990967
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and outcomes of sentinel node-positive breast cancer patients after total mastectomy without axillary-specific treatment.
Milgrom S; Cody H; Tan L; Morrow M; Pesce C; Setton J; Rogers K; Arnold B; Eaton A; Catalano J; McCormick B; Powell S; Ho A
Ann Surg Oncol; 2012 Nov; 19(12):3762-70. PubMed ID: 22576064
[TBL] [Abstract][Full Text] [Related]
13. Erratum to: Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up.
Kiluk JV; Ly QP; Santillan AA; Meade T; Ramos D; Reintgen DS; Dessureault S; Davis M; Shamehdi C; Cox CE
Ann Surg Oncol; 2010 Feb; 17(2):552-7. PubMed ID: 19957043
[TBL] [Abstract][Full Text] [Related]
14. Omission of axillary lymph node dissection for clinically node negative early-stage breast cancer patients.
Kobayashi R; Shiraishi K; Iwase S; Ohtomo K; Nakagawa K
Breast Cancer; 2015 Nov; 22(6):657-63. PubMed ID: 24756246
[TBL] [Abstract][Full Text] [Related]
15. Microinvasive breast cancer: ER, PR, and HER-2/neu status and clinical outcomes after breast-conserving therapy or mastectomy.
Margalit DN; Sreedhara M; Chen YH; Catalano PJ; Nguyen PL; Golshan M; Overmoyer BA; Harris JR; Brock JE
Ann Surg Oncol; 2013 Mar; 20(3):811-8. PubMed ID: 22956068
[TBL] [Abstract][Full Text] [Related]
16. Predicting axillary sentinel node status in patients with primary breast cancer.
Kolarik D; Pecha V; Skovajsova M; Zahumensky J; Trnkova M; Petruzelka L; Halaska M; Sottner O; Otcenasek M; Kolarova H
Neoplasma; 2013; 60(3):334-42. PubMed ID: 23374005
[TBL] [Abstract][Full Text] [Related]
17. Axillary reverse mapping in breast cancer: a Canadian experience.
Kuusk U; Seyednejad N; McKevitt EC; Dingee CK; Wiseman SM
J Surg Oncol; 2014 Dec; 110(7):791-5. PubMed ID: 25053441
[TBL] [Abstract][Full Text] [Related]
18. Sentinel Node Biopsy in Early Breast Cancer Patients with Palpable Axillary Node.
Shojaee L; Abedinnegad S; Nafisi N; Naghshvar F; Godazandeh G; Moradi S; Shakeri Astani K; Godazandeh Y
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1631-1636. PubMed ID: 32592357
[TBL] [Abstract][Full Text] [Related]
19. Predictors of completion axillary lymph node dissection in patients with immunohistochemical metastases to the sentinel lymph node in breast cancer.
Pugliese MS; Karam AK; Hsu M; Stempel MM; Patil SM; Ho AY; Traina TA; Van Zee KJ; Cody HS; Morrow M; Gemignani ML
Ann Surg Oncol; 2010 Apr; 17(4):1063-8. PubMed ID: 20033325
[TBL] [Abstract][Full Text] [Related]
20. Sentinel Node and Recurrent Breast Cancer (SNARB): results of a nationwide registration study.
Maaskant-Braat AJ; Roumen RM; Voogd AC; Pijpers R; Luiten EJ; Rutgers EJ; Nieuwenhuijzen GA
Ann Surg Oncol; 2013 Feb; 20(2):620-6. PubMed ID: 22941173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]